Catalyst Wire Dossier Catalyst Wire Dossier

Cixutumumab

Cixutumumab · ImClone Systems (Eli Lilly)
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Cixutumumab, covering 2013-04-23 to 2019-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]

See pricing